176894-58-9

Basic information

• Product Name: (R)-benzyl 1-cyanoethylcarbaMate
• Synonyms: (R)-benzyl 1-cyanoethylcarbaMate;N-[(1R)-1-Cyanoethyl]carbamic acid phenylmethyl ester
• CAS NO: 176894-58-9
• Molecular Formula: C₁₁H₁₂N₂O₂
• Molecular Weight: 204.22518
• Mol File: 176894-58-9.mol
• Article Data: 6

Chemical Properties

• Melting Point: 82-83℃
• Appearance: /
• Density: 1.148
• CAS DataBase Reference: (R)-benzyl 1-cyanoethylcarbaMate(CAS DataBase Reference)
• NIST Chemistry Reference: (R)-benzyl 1-cyanoethylcarbaMate(176894-58-9)
• EPA Substance Registry System: (R)-benzyl 1-cyanoethylcarbaMate(176894-58-9)

Safety Data

• Hazardous Substances Data: 176894-58-9(Hazardous Substances Data)

Usage

General Description

(R)-benzyl 1-cyanoethylcarbaMate is a chemical compound with the molecular formula C14H15NO2. It is a carbamate derivative and has a benzyl group attached to the nitrogen atom. (R)-benzyl 1-cyanoethylcarbaMate is mainly used as a reagent in organic synthesis and pharmaceutical research. It is known for its role as a chiral auxiliary in asymmetric synthesis and can be used to introduce stereochemical control in various chemical reactions. Additionally, it has potential applications in the development of pharmaceuticals and agricultural products. This chemical compound is considered to be stable under normal conditions and has low toxicity. Overall, (R)-benzyl 1-cyanoethylcarbaMate has versatile uses in chemical and pharmaceutical industries due to its unique structural and chiral properties.

Upstream product

• 28819-05-8 N-benzyloxycarbonyl-D-alanine methyl ester 
• 102988-93-2 C₁₆H₂₁NO₆ 
• 26607-51-2 N-benzyloxycarbonyl-D-alanine 
• 151378-81-3 benzyl [(1R)-2-amino-1-methyl-2-oxoethyl]carbamate 

Downstream Products

• 1150262-33-1 benzyl [(1R)-1-(5-methyl-1,2,4-oxadiazol-3-yl)ethyl]carbamate 
• 1150566-62-3 benzyl [(1R,2Z)-2-amino-2-(hydroxyimino)-1-methylethyl]carbamate 
• 34276-31-8 benzyl N-[(1R)-1-(1H-1,2,3,4-tetrazol-5-yl)ethyl]carbamate 

Relevant articles and documents

C-terminal 1-aminoethyltetrazole-containing oligopeptides as novel alanine racemase inhibitors

In clinical culture media inoculated with patient samples, selective inhibition of commensal bacteria is essential for accurate diagnosis and effective treatment, as they can mask the presence of pathogenic bacteria. The alanine analogue, 1-aminoethyltetr

P2X3, RECEPTOR ANTAGONISTS FOR TREATMENT OF PAIN

The subject invention relates to novel P2X3 receptor antagonists that play a critical role in treating disease states associated with pain, in particular peripheral pain, inflammatory pain, or tissue injury pain that can be treated using a P2X3 receptor subunit modulator.

Design and synthesis of cyclopenta[g]quinazoline-based antifolates as inhibitors of thymidylate synthase and potential antitumor agents

Following the development of raltitrexed, the synthesis of nonpolyglutamatable inhibitors of TS that do not use the reduced folate carrier (RFC) for cellular entry should provide compounds which overcome mechanisms of resistance to folate-based inhibitors